Global Blood Therapeutics, Inc. Debt to Equity Ratio 2015-2022 | GBT
Current and historical debt to equity ratio values for Global Blood Therapeutics, Inc. (GBT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Global Blood Therapeutics, Inc. debt/equity for the three months ending June 30, 2022 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2022-06-30 | $0.75B | $0.12B | 6.35 |
| 2022-03-31 | $0.74B | $0.13B | 5.49 |
| 2021-12-31 | $0.74B | $0.20B | 3.78 |
| 2021-09-30 | $0.30B | $0.31B | 0.97 |
| 2021-06-30 | $0.30B | $0.32B | 0.95 |
| 2021-03-31 | $0.29B | $0.36B | 0.79 |
| 2020-12-31 | $0.31B | $0.42B | 0.74 |
| 2020-09-30 | $0.23B | $0.46B | 0.51 |
| 2020-06-30 | $0.23B | $0.50B | 0.46 |
| 2020-03-31 | $0.22B | $0.52B | 0.42 |
| 2019-12-31 | $0.22B | $0.58B | 0.38 |
| 2019-09-30 | $0.07B | $0.66B | 0.11 |
| 2019-06-30 | $0.07B | $0.70B | 0.09 |
| 2019-03-31 | $0.06B | $0.56B | 0.10 |
| 2018-12-31 | $0.05B | $0.57B | 0.08 |
| 2018-09-30 | $0.04B | $0.47B | 0.08 |
| 2018-06-30 | $0.03B | $0.51B | 0.07 |
| 2018-03-31 | $0.04B | $0.54B | 0.07 |
| 2017-12-31 | $0.04B | $0.32B | 0.12 |
| 2017-09-30 | $0.03B | $0.26B | 0.10 |
| 2017-06-30 | $0.02B | $0.28B | 0.07 |
| 2017-03-31 | $0.02B | $0.30B | 0.05 |
| 2016-12-31 | $0.02B | $0.19B | 0.09 |
| 2016-09-30 | $0.01B | $0.21B | 0.07 |
| 2016-06-30 | $0.01B | $0.22B | 0.07 |
| 2016-03-31 | $0.01B | $0.13B | 0.10 |
| 2015-12-31 | $0.01B | $0.14B | 0.08 |
| 2015-09-30 | $0.01B | $0.16B | 0.05 |
| 2015-06-30 | $0.01B | $0.04B | 0.18 |
| 2015-03-31 | $0.01B | $0.05B | 0.10 |
| 2014-12-31 | $0.00B | $0.05B | 0.06 |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
